The comparison of efficacy and outcomes of Triptorelin (Diphereline®) and hCG in ovulation trigger in infertile women with poly cystic ovarian syndrome

Phase 3

Recruiting

• Conditions: Infertility in women with Poly cystic ovarian syndrome.; Polycystic ovarian syndrome; E28.2

• Registration Number: IRCT20200122046221N3
• Lead Sponsor: Jahrom University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 4 April 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 120

Inclusion Criteria

Infertile women who do not become pregnant one year after cohabitation and intercourse without the use of contraceptives
From 15 years old to 45 years old
With Poly cystic ovarian syndrome

Exclusion Criteria

Semen analysis and abnormal hysterosalpingography
Over 45 years old
Myoma
Hyperprolactinemia
Hypothyroidism
Hyperthyroidism
FSH> 12
Women with endometriosis
History of contact with any substance induced by previous ovulation
Kidney and liver disease
Any contraindications to Diphereline and hCG
Male factor

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pregnancy. Timepoint: End of menstrual cycle. Method of measurement: Serum b-hCG.

Secondary Outcome Measures

Name	Time	Method
Incidence of ovarian hyperstimulation syndrome. Timepoint: End of menstrual cycle. Method of measurement: Clinical signs and ultrasound.;Incidence of multiple birth. Timepoint: End of menstrual cycle. Method of measurement: ultrasound sonography.